Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-054799
Filing Date
2014-08-28
Accepted
2014-08-28 13:23:20
Documents
1
Period of Report
2014-08-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3740
  Complete submission text file 0001209191-14-054799.txt   5100
Mailing Address 975 GLADESTRY LANE LOWER GWYNEDD PA 19002
Business Address
CARROLL J MARTIN (Reporting) CIK: 0001279901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35599 | Film No.: 141071027

Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Issuer) CIK: 0001544116 (see all company filings)

EIN.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations